NCT01339884View on ClinicalTrials.gov

A Study of Resveratrol as Treatment for Friedreich Ataxia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2012

Conditions
Friedreich Ataxia
Interventions
DRUG

Resveratrol

Resveratrol 1g daily (500mg twice daily) for 12 weeks Resveratrol 5 daily (2.5g twice daily) for 12 weeks

Trial Locations (1)

3168

Monash Medical Centre, Southern Health, Clayton, Melbourne

Sponsors
All Listed Sponsors
collaborator

Friedreich's Ataxia Research Alliance

OTHER

lead

Murdoch Childrens Research Institute

OTHER